Effects of CCK-tetrapeptide in patients
β
Martin A. Katzman; Diana Koszycki; Jacques Bradwejn
π
Article
π
2004
π
John Wiley and Sons
π
English
β 105 KB
π 1 views
Panicogenic sensitivity to CCK-tetrapeptide (CCK-4) is enhanced in panic disorder patients relative to normal controls (NC). We sought to determine whether CCK-4 sensitivity is augmented in patients with social phobia (SP) (n ΒΌ 12) and obsessive-compulsive disorder (OCD) (n ΒΌ 8) versus NC (n ΒΌ 12).